Cargando…
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly variable disease severity and a bimodal course characterized by acute respiratory viral infection followed by hyperinflammation in a subset of patients with severe disease. This immune dysregulation is characterized b...
Autores principales: | Goldman, Jason D, Robinson, Philip C, Uldrick, Thomas S, Ljungman, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206176/ https://www.ncbi.nlm.nih.gov/pubmed/34117116 http://dx.doi.org/10.1136/jitc-2021-002630 |
Ejemplares similares
-
Viral Infections in Immunocompromised Patients
por: Englund, Janet, et al.
Publicado: (2011) -
“Living with COVID”—implications for immunosuppressed and immunocompromised
por: Nune, A., et al.
Publicado: (2022) -
Immunotherapy in People With HIV and Cancer
por: Puronen, Camille E., et al.
Publicado: (2019) -
Foreword: Preventing COVID-19 Among the Immunocompromised Population
por: Willicombe, Michelle
Publicado: (2023) -
The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
por: Antinori, Andrea, et al.
Publicado: (2023)